vs
Side-by-side financial comparison of loanDepot, Inc. (LDI) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $310.3M, roughly 1.6× loanDepot, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -7.2%, a 14.1% gap on every dollar of revenue. On growth, loanDepot, Inc. posted the faster year-over-year revenue change (20.5% vs -1.7%). Over the past eight quarters, loanDepot, Inc.'s revenue compounded faster (18.0% CAGR vs -0.1%).
LoanDepot, sometimes stylized as loanDepot, is an Irvine, California-based nonbank holding company which sells mortgage and non-mortgage lending products.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
LDI vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $310.3M | $493.8M |
| Net Profit | $-22.5M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | -10.3% | 9.9% |
| Net Margin | -7.2% | 6.8% |
| Revenue YoY | 20.5% | -1.7% |
| Net Profit YoY | 32.4% | 10.5% |
| EPS (diluted) | — | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $310.3M | $493.8M | ||
| Q3 25 | $323.3M | $492.9M | ||
| Q2 25 | $282.5M | $468.8M | ||
| Q1 25 | $273.6M | $458.4M | ||
| Q4 24 | $257.5M | $502.4M | ||
| Q3 24 | $314.6M | $511.2M | ||
| Q2 24 | $265.4M | $504.3M | ||
| Q1 24 | $222.8M | $495.1M |
| Q4 25 | $-22.5M | $33.7M | ||
| Q3 25 | $-4.9M | $71.7M | ||
| Q2 25 | $-13.4M | $39.3M | ||
| Q1 25 | $-21.9M | $20.7M | ||
| Q4 24 | $-33.2M | $30.5M | ||
| Q3 24 | $1.4M | $19.4M | ||
| Q2 24 | $-32.2M | $-153.0M | ||
| Q1 24 | $-34.3M | $4.0M |
| Q4 25 | -10.3% | 9.9% | ||
| Q3 25 | -3.2% | 13.8% | ||
| Q2 25 | -11.4% | 12.8% | ||
| Q1 25 | -16.8% | 7.0% | ||
| Q4 24 | -32.7% | 7.8% | ||
| Q3 24 | 1.1% | 6.6% | ||
| Q2 24 | -29.1% | -31.3% | ||
| Q1 24 | -38.2% | 3.2% |
| Q4 25 | -7.2% | 6.8% | ||
| Q3 25 | -1.5% | 14.5% | ||
| Q2 25 | -4.7% | 8.4% | ||
| Q1 25 | -8.0% | 4.5% | ||
| Q4 24 | -12.9% | 6.1% | ||
| Q3 24 | 0.4% | 3.8% | ||
| Q2 24 | -12.1% | -30.3% | ||
| Q1 24 | -15.4% | 0.8% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | $0.01 | $0.23 | ||
| Q2 24 | $-0.18 | $-1.84 | ||
| Q1 24 | $-0.19 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $337.2M | $375.2M |
| Total DebtLower is stronger | $2.1B | $570.5M |
| Stockholders' EquityBook value | $386.0M | $865.9M |
| Total Assets | $6.9B | $2.2B |
| Debt / EquityLower = less leverage | 5.44× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $337.2M | $375.2M | ||
| Q3 25 | $459.2M | $340.1M | ||
| Q2 25 | $408.6M | $224.7M | ||
| Q1 25 | $371.5M | $99.0M | ||
| Q4 24 | $421.6M | $229.9M | ||
| Q3 24 | $483.0M | $103.8M | ||
| Q2 24 | $533.2M | $19.4M | ||
| Q1 24 | $603.7M | $8.0M |
| Q4 25 | $2.1B | $570.5M | ||
| Q3 25 | $2.1B | $577.2M | ||
| Q2 25 | $2.1B | $583.9M | ||
| Q1 25 | $2.0B | $590.5M | ||
| Q4 24 | $2.0B | $597.1M | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.3B | — |
| Q4 25 | $386.0M | $865.9M | ||
| Q3 25 | $433.3M | $890.7M | ||
| Q2 25 | $439.1M | $833.8M | ||
| Q1 25 | $469.3M | $789.2M | ||
| Q4 24 | $506.6M | $764.9M | ||
| Q3 24 | $592.0M | $732.5M | ||
| Q2 24 | $578.9M | $706.5M | ||
| Q1 24 | $637.3M | $856.2M |
| Q4 25 | $6.9B | $2.2B | ||
| Q3 25 | $6.2B | $2.2B | ||
| Q2 25 | $6.2B | $2.1B | ||
| Q1 25 | $6.4B | $2.0B | ||
| Q4 24 | $6.3B | $2.2B | ||
| Q3 24 | $6.4B | $2.1B | ||
| Q2 24 | $5.9B | $2.0B | ||
| Q1 24 | $6.2B | $2.2B |
| Q4 25 | 5.44× | 0.66× | ||
| Q3 25 | 4.83× | 0.65× | ||
| Q2 25 | 4.70× | 0.70× | ||
| Q1 25 | 4.30× | 0.75× | ||
| Q4 24 | 4.00× | 0.78× | ||
| Q3 24 | 3.31× | — | ||
| Q2 24 | 3.41× | — | ||
| Q1 24 | 3.63× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-638.7M | $114.1M |
| Free Cash FlowOCF − Capex | $-648.0M | — |
| FCF MarginFCF / Revenue | -208.9% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-734.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-638.7M | $114.1M | ||
| Q3 25 | $43.4M | $137.3M | ||
| Q2 25 | $67.6M | $137.2M | ||
| Q1 25 | $-179.9M | $-117.5M | ||
| Q4 24 | $47.7M | $133.0M | ||
| Q3 24 | $-349.2M | $91.8M | ||
| Q2 24 | $-278.3M | $107.0M | ||
| Q1 24 | $-278.5M | $-125.2M |
| Q4 25 | $-648.0M | — | ||
| Q3 25 | $38.7M | — | ||
| Q2 25 | $61.4M | — | ||
| Q1 25 | $-186.7M | — | ||
| Q4 24 | $40.8M | — | ||
| Q3 24 | $-356.4M | — | ||
| Q2 24 | $-285.7M | — | ||
| Q1 24 | $-283.3M | — |
| Q4 25 | -208.9% | — | ||
| Q3 25 | 12.0% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | -68.2% | — | ||
| Q4 24 | 15.8% | — | ||
| Q3 24 | -113.3% | — | ||
| Q2 24 | -107.7% | — | ||
| Q1 24 | -127.2% | — |
| Q4 25 | 3.0% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 2.1% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | -255.05× | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LDI
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
